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Abstract The impact of a moderate Zn deﬁciency on
growth and plasma and liver lipids was investigated in two
4-week experiments with male weanling rats fed fat-enri-
ched diets. Semisynthetic, approximately isocaloric diets
containing 3% soybean oil were supplemented with either 7
or 100 mg Zn/kg diet and with 22% beef tallow (BT) or
sunﬂower oil (SF). In Experiment 1, which compared the
dietary fat level and the fat source in a factorial design of
treatments, all diets were fed ad libitum to 6 9 8 animals,
whereas intake of the high-Zn BT and SF diets was
restricted in Experiment 2 (5 9 6 rats) to the level of intake
of the respective low-Zn diets. The low-Zn SF diet con-
sistently depressed food intake and ﬁnal live weights of the
animals to a greater extent than the other low-Zn diets,
while intake and growth were comparable among the ani-
mals fed the high-Zn diets. The marginal Zn deﬁcit per se
did not alter plasma triglyceride and cholesterol concen-
trations nor hepatic concentrations of triglyceride, choles-
terol and phospholipids. The fatty acid pattern of liver
phospholipids did not indicate that chain elongation and
desaturation of fatty acids was impaired by a lack of zinc. It
was concluded that dietary energy and fat intake, and fat
source have a greater effect on plasma and liver lipids than a
moderate Zn deﬁciency. Marginally Zn-deﬁcient diets
enriched with sunﬂower oil as a major energy source cause
a greater growth retardation than diets rich in carbohydrates
or beef tallow.
Keywords Zinc deﬁciency  Growth  Plasma lipids 
Liver lipids  Fatty acid metabolism  Rats
Abbreviations
ANOVA Analysis of variance
AP Alkaline phosphatase
BT Beef tallow
CT Control
DNL De novo lipogenesis
GE Gross energy
G6PD Glucose-6-phosphate dehydrogenase
HDL-C High density lipoprotein cholesterol
ME Metabolizable energy
MUFA Monounsaturated fatty acid(s)
PUFA Polyunsaturated fatty acid(s)
PL Phospholipids
SF Sunﬂower (seed) oil
SFA Saturated fatty acid(s)
TAG Triacylglycerol(s)
TC Total cholesterol
VLDL Very low density lipoproteins
Zn Zinc
Introduction
In young animals, early signs of severe zinc (Zn) deﬁciency
are growth retardation, depressed food intake and a cyclic
feeding pattern [1–3]. The dietary fat source and fat level
may alter the effects of dietary Zn depletion on growth rate
and lipid metabolism. Bettger et al. [4] found that dietary
substitution of 5% hydrogenated coconut oil for corn oil as a
source of essential fatty acids improved the growth of young
rats, suggesting an interaction between these nutrients. In
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DOI 10.1007/s11745-011-3629-ysimilar studies with chicks [5], the effects were the oppo-
site. The addition of corn oil, soybean oil or a mixture of
polyunsaturated fatty acids (PUFA) to Zn-deﬁcient diets
retarded growth of the animals to a greater extent as com-
pared to hydrogenated coconut oil and exacerbated the
symptoms of Zn deﬁciency. Huang et al. [6] reported that
growth retardation of young rats was partially alleviated
when the animals were given daily subcutaneous injections
of primrose oil, but when safﬂower oil was injected the
effect was minimal. In a recent study [7], fat source in fat-
enriched diets markedly affected growth rates of weanling
rats when the dietary Zn supply was marginal, i.e. about
two-third of the minimum requirement for unlimited
growth.Low-Zn diets supplemented with 18% sunﬂower oil
or olive oil depressed ﬁnal live weights of the animals to a
greater extent than diets enriched with beef tallow, whereas
no difference was evident among corresponding high-Zn
diets.
The objective of the present study was to investigate the
impact of highly fat-enriched diets on growth and lipid
metabolism of weanling rats when dietary Zn supply is
either marginal or adequate for unlimited growth. Semi-
synthetic diets were supplemented with 7 or 100 lg Zn/g
and were enriched with 22% fat as beef tallow (BT) or as
sunﬂower oil (SF) above a basal fat content of 3% soybean
oil in all diets. In a ﬁrst experiment, which included diets
without supplemental fat, all diets were fed ad libitum for 4
weeks, whereas intake of the high-Zn diets was restricted in
a second experiment according to the intake of the
respective low-Zn BT and SF diets. The low-Zn SF diet
consistently reduced food and energy intake and ﬁnal live
weights to a greater extent than the other low-Zn diets.
Changes in plasma and liver lipids observed in response to
dietary treatments were primarily attributable to differ-
ences in energy and fat intake and to fat source rather than
to the moderate Zn deﬁciency. We conclude that dietary
energy and fat intake, and fat source have a greater effect
on plasma and liver lipids than a moderate Zn deﬁcit, and
that Zn-deﬁcient diets enriched with sunﬂower oil as a
major energy source cause a greater growth retardation
than diets rich in carbohydrates or beef tallow.
Experimental Procedures
Animals and Diets
In Experiment 1, a total of 48 male weanling Wistar rats
(Harlan Winkelmann, Borchen, Germany) with an initial
live weight of 48 ± 2.8 g (mean ± SD) were randomly
assigned to six treatment groups of eight animals each,
following a 2 9 3 factorial design for dietary Zn and fat
treatments. Semisynthetic diets for these groups differed in
Zn supplementation (7 vs. 100 lg/g, added as
ZnSO47H2O), and in fat supplementation: 22% beef tallow
(BT) or 22% sunﬂower oil (SF) versus a low-fat, carbo-
hydrate-rich control diet (CT). All diets contained 3%
soybean oil to offer sufﬁcient amounts of essential fatty
acids. The major components of the diets are summarized
in Table 1. They contributed a basal Zn level of about 0.5
lg/g by analysis. In the high-fat diets parts of cornstarch
were replaced by cellulose to compensate for differences in
energy. The fatty acid composition of the low- and high-fat
diets is shown in Table 2. Diets were stored at 4 C. Ad
libitum feeding was practiced, replacing remainders by
fresh portions daily.
In Experiment 2, six male weanling rats each
(50 ± 2.8 g initial live weight) were randomly allocated to
ﬁve dietary treatments: (1) low-Zn BT diet fed ad libitum,
(2) high-Zn BT diet fed in restricted amounts according to
Table 1 Composition of the experimental diets (Experiment 1 and 2)
Low-fat
diets
High-fat diets
Control
(CT)
BT diets SF diets
Ingredients (g/kg diet)
Egg albumen 200 200 200
Cornstarch
a 527 77 77
Sucrose 100 100 100
Cellulose 50 280 280
Vitamin premix
b 15 15 15
Mineral premix
b 50 50 50
Zinc premix
c 25 25 25
L-Lysine ? DL-methionine (1:1) 3 3 3
Soybean oil 30 30 30
Beef tallow (BT) – 220 –
Sunﬂower oil (SF) – – 220
Total 1,000 1,000 1,000
Nutrient composition (by analysis)
Protein content (g/kg DM) 179 176 177
Fat content (g/kg DM) 36 260 263
NDF content (g/kg DM) 134 276 280
ME content (MJ/kg DM) 16.7 17.0 17.6
Carbohydrate energy (% of ME) 69 22 21
Fat energy (% of ME) 8 55 58
DM dry matter, NDF neutral detergent ﬁber, ME metabolizable
energy
a Additional cornstarch was contained in the mineral, vitamin and
zinc premixes (total of 43.5 g/kg)
b Details of the vitamin and mineral mixtures have been reported
previously [8]
c Zinc premix provided 7 or 100 lg Zn/g diet as ZnSO47H2O above
a basal level of 0.5 lg/g diet
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123average intake of group 1, (3) low-Zn SF diet fed ad libi-
tum, (4) high-Zn SF diet fed in restricted amounts
according to average intake of group 3, and (5) high-Zn SF
diet fed ad libitum. Diet composition was the same as
described in Tables 1 and 2 regarding ingredients, Zn and
fat supplementation. Food consumption was determined
daily to control intake of the rats in group 2 and 4.
Approval of the experimental protocols for use and care
of laboratory animals in research was obtained by the
regional Animal Protection Authority (Regierungspra ¨sidi-
um Giessen, II 25.3-19c20/15c GI 19/3). The rats were
housed individually in stainless steel metabolic cages in
an environmentally controlled room (22 C, rel. humidity
of 55%, 12 h light and dark cycle). They had free access
to deionized water. In Experiment 1, feces were collected
daily during week 2 and 3, freeze-dried and stored at 4 C
for determination of energy and fat content. After
4 weeks, the animals were fasted overnight and anesthe-
tized with carbon dioxide followed by decapitation. Blood
was collected in test tubes containing heparin and centri-
fuged (3,000g for 10 min at 4 C), and the resulting
plasma was stored at -80 C. The liver and right femur
were excised, weighed and frozen on dry ice for sub-
sequent measurements.
Analytical Procedures
Diets were analyzed for dry matter, crude protein, fat and
neutral detergent ﬁber by ofﬁcial methods [9]. Fecal sam-
ples were treated with 4 M HCl before fat extraction using
n-hexane. Gross energy (GE) in diets and feces was
determined by adiabatic bomb calorimetry. The metabo-
lizable energy (ME) of the low- and high-fat diets was
calculated as digestible energy (intake minus fecal excre-
tion of GE during week 2 and 3 of Experiment 1) multi-
plied by 0.96 [10].
Zn concentration in the femur bone and diets was ana-
lyzed by ICP-AES (inductively coupled plasma atomic
emission spectrometry) after dry-ashing (450 C) and dis-
solving in 3 M HNO3. Plasma Zn concentration was
measured directly after dilution with 0.1 M hydrochloric
acid by ﬂame atomic absorption spectrometry. The activity
of the alkaline phosphatase (AP; EC 3.1.3.1) in plasma was
determined photometrically with a standard method [11].
The activity of the glucose-6-phosphate dehydrogenase
(G6PD; EC 1.1.1.49) in liver homogenates was assayed
with a commercial reagent kit (Boehringer Mannheim
GmbH, Germany). The protein content in liver homoge-
nates was determined by the Lowry method [12].
Liver total lipids were extracted with a mixture of
hexane:isopropanol (3:2, by vol) according to the method
of Hara and Radin [13] with minor modiﬁcations. Brieﬂy,
frozen liver was weighed and homogenized in 0.15 M
NaCl solution. Hexane:isopropanol (3:2, by vol), con-
taining 0.005% (wt/vol) butylhydroxytoluol, was added
and the mixture centrifuged for 10 min at 3,000g and
10 C. The upper organic phase was collected and the
solvent evaporated under liquid nitrogen. The resulting
residues were quantiﬁed gravimetrically as total lipids and
resuspended in hexane:isopropanol (3:2, by vol). Aliquots
of the liver lipid extracts and plasma samples were ana-
lyzed for their content of triglycerides and cholesterol
using commercial test kits (Ecoline 25, Merck KGaA,
Darmstadt, Germany). The phospholipid (PL) content was
quantiﬁed by phosphate measurement in aliquots of the
liver lipid extracts using a commercial test combination
for phosphorus and phospholipids (Boehringer Mannheim
GmbH, Germany).
Liver PL were separated from the total lipid extracts for
subsequent fatty acid analysis by aminopropyl-bonded
phase columns (Bond Elut, Agilent Technologies); this
solid phase extraction method has been shown to be
superior to other separation techniques [14]. Aliquots of
liver lipid extracts were dissolved in chloroform and
applied to hexane pre-conditioned columns. After treat-
ment with several other solvents that released neutral lipids
and free fatty acids from the column, methanol was added
to provoke the elution of the PL fraction. These fractions,
to which heptadecanoic acid (17:0) was added as internal
standard, were subjected to transmethylation with N-tri-
methyl sulfonium hydroxide. Fatty acid methyl esters
(FAME) were separated by gas chromatography. They
were identiﬁed by comparing retention times of FAME in a
standard mix (Supelco 37, Sigma-Aldrich, Inc) that was
supplemented with docosapentaenoic acid (D5679, Sigma-
Aldrich, Inc). Individual FA were quantiﬁed on the basis of
area under the curve and internal standard response as
molar percentage of the total amount of fatty acids.
Table 2 Fatty acid composition of experimental diets (mol/100 mol
fatty acid)
Fatty acid
a CT diets BT diets SF diets
Myristic acid 0.21 6.73 0.11
Palmitic acid 16.7 25.5 7.51
Palmitoleic acid 0.0 3.09 0.19
Stearic acid 3.90 15.6 3.43
Oleic acid 21.1 35.1 26.1
Linoleic acid 51.1 11.2 60.5
a-Linolenic acid 5.68 1.44 0.85
Values are means of three independent determinations per diet
a The concentration of additional fatty acids was less than 1.5 mol/
100 mol across diets
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Statistical analyses were performed using IBM SPSS Sta-
tistics 19 for Windows (IBM Company, Chicago, IL, USA).
Data were analyzed by two-way analysis of variance
(ANOVA) according to the linear model for a completely
randomized design to test for treatment effects of Zn, fat
and Zn 9 fat interaction (2 9 3-factorial in Expt. 1 and
2 9 2-factorial in Expt. 2). Since the factor ‘‘fat’’ included
fat level (low vs. high) and fat source (BT vs. SF) in
Experiment 1, bifactorial ANOVA was also applied to the
high-fat treatments to test for effects of fat source. In
addition, univariate analysis was applied to test for differ-
ences among groups within each dietary Zn level in
Experiment 1 and among the three groups fed the SF diets in
Experiment 2. The Tukey test was used as a post hoc test to
compare treatment means or, alternatively, the Games–
Howell test if homogeneity of variance (Levene test) could
not be attained by logarithmic (ln) or square root transfor-
mation of the data. The signiﬁcance was set at p\0.05 in
post hoc tests.
Results
Experiment 1
Food and Energy Intake and Final Live Weight
In Experiment 1, in which all diets were offered ad libitum
during the 28-days feeding period, the marginal Zn sup-
plementation of the diets markedly (p\0.001) reduced
food and energy intake and ﬁnal live weights (Table 3). ME
intakeandﬁnalliveweightssigniﬁcantlydifferedamongthe
rats fed the low-Zn diets, but not among the animals fed the
high-Zn diets. Both level and source of dietary fat contrib-
uted to a signiﬁcant Zn 9 fat interaction, as the reductions
in ME intake and ﬁnal live weights due to the moderate Zn
deﬁciency differed among the CT, BT and SF groups (about
14, 22 and 30% in ME intake and 12, 19 and 28% in ﬁnal
weights relative to the respective high-Zn groups). ME
intake per gram of weight gain was signiﬁcantly higher for
the rats fed the low-Zn diets, but the difference was rela-
tively small (less than 7%), and may be attributed primarily
Table 3 Effect of diets differing in Zn concentration and fat
supplementation on food and energy (ME) intake, ﬁnal live weight,
fat and energy digestibility, plasma and femur Zn concentration,
plasma alkaline phosphatase activity, and liver glucose-6-phosphate
dehydrogenase (G6PD) activity in weanling rats (Experiment 1)
Diet Zn concentration 7 lg/g 100 lg/g ANOVA: p values
Fat supplement CT BT SF CT BT SF Zn Fat Zn 9 Fat
Food intake (g/day) M 14.4
c 11.8
b 9.9
a 16.6
b 15.1
a 14.3
a \0.001 \0.001 NS
SD 1.6 1.8 1.6 0.7 0.8 1.1
ME intake
d (kJ/day) M 216
b 189
ab 166
a 250
a 242
a 238
a \0.001 \0.001 \0.05
SD 24 28 26 10 13 18
ME intake (kJ/g wt gain) M 39.1
a 38.2
a 40.1
a 38.2
a 37.1
a 37.5
a \0.05 NS NS
SD 2.7 1.2 1.9 1.3 3.6 2.1
Final live weight (g) M 204
b 188
b 165
a 232
a 233
a 228
a \0.001 \0.01 \0.05
SD 17 22 20 8 20 18
Fat digestibility (%) M 97.6
b 89.7
a 98.2
b 97.0
b 89.1
a 98.7
b NS \0.001 NS
SD 0.9 1.5 0.3 0.6 0.9 0.4
GE digestibility (%) M 93.7
c 73.9
a 77.6
b 93.1
c 73.3
a 77.9
b NS \0.001 NS
SD 0.2 0.5 0.5 0.7 0.7 0.6
Plasma zinc (lg/mL) M 1.36
b 1.11
a 0.90
a 2.04
c 1.86
b 1.65
a \0.001 \0.001 NS
SD 0.20 0.22 0.25 0.12 0.20 0.14
Femur zinc
d (lg/g fresh wt) M 51.9
a 46.9
a 48.0
a 134
b 123
a 123
a \0.001 \0.01 NS
SD 4.5 4.6 4.3 5.9 7.3 11.1
Plasma AP (mU/mL) M 378
a 383
a 415
a 445
a 529
b 543
b \0.001 \0.01 NS
SD 62 76 62 59 50 44
Liver G6PD
d (mU/mg protein) M 51.9
b 12.6
a 12.3
a 50.6
b 13.7
a 18.5
a NS \0.001 NS
SD 22.4 2.6 2.2 17.0 4.6 7.7
GE gross energy, ME metabolizable energy, NS not signiﬁcant, SD standard deviation
a, b, c Group means (M) with different superscript letters within rows and within the same zinc level signiﬁcantly differ (p\0.05; Tukey test; in
the case of G6PD Games–Howell test)
d ANOVA after ln transformation of data
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123to a higher proportion of energy expended for maintenance
in the animals fed the low-Zn diets.
Fat and Energy Digestibility
Fat digestibility in the BT groups was approximately
8–9% U lower than in the CT and SF groups independent of
the dietary Zn level (Table 3). This difference may be
attributed to the high content of saturated fatty acids in beef
tallow. Gross energy (GE) digestibility of the BT and SF
diets was markedly lower than that of the CT diets (about 20
and 15% U, respectively; p\0.001), reﬂecting the pro-
nounced difference in dietary cellulose content. GE digest-
ibilityalsosigniﬁcantly(p\0.001)differedbetweentheBT
and SF diets according to the difference in fat digestibility.
Zinc and Metabolic Status
Zn concentrations in plasma and femur and activity of the
alkaline phosphatase (AP) in plasma, which were analyzed
as indicators of Zn status, were substantially reduced
(p\0.001) by the marginal dietary Zn supply in Experi-
ment 1 (Table 3). Dietary fat level and fat source also
affected these parameters to different degrees. Plasma Zn
concentrations were lower in the rats fed the high-fat diets
as compared to those fed the CT diets. This difference was
most marked for the SF-fed animals. The plasma AP
activity was enhanced by the high-fat diets.
The activity of glucose-6-phosphate dehydrogenase
(G6PD), a member of the lipogenic enzyme family [15],
was greatly reduced (p\0.001) in the liver of the rats fed
the high-fat diets as compared to those given the low-fat
CT diet, regardless of the dietary Zn level (Table 3).
Plasma and Liver Lipids
Plasma concentrations of triglycerides (TAG), total cho-
lesterol (TC) and HDL-C were not signiﬁcantly altered by
the dietary Zn level, but they were by the level and type of
fat in the diets in Experiment 1 (Table 4). The SF diets
consistently reduced plasma TAG concentrations regardless
of the dietary Zn level. TC and HDL-C concentrations in the
low-Zn CT group were signiﬁcantly higher (p\0.05) than
in the low-Zn BT and SF groups, but not when the dietary
Zn level was high. Fat source did not signiﬁcantly affect
plasma TC and HDL-C concentrations.
Liver concentrations of total lipids, TAG and cholesterol
(Table 4) were signiﬁcantly higher in the rats fed the high-
Zn BT and SF diets than in those fed the respective low-Zn
diets, while they did not differ between the two CT-fed
groups. Concentrations of these lipids were substantially
higher for the SF-fed than for the BT-fed animals
Table 4 Effect of diets differing in Zn concentration and fat supplementation on plasma and liver lipid concentrations (Experiment 1)
Diet Zn concentration 7 lg/g 100 lg/g ANOVA: p values
Fat supplement CT BT SF CT BT SF Zn Fat Zn 9 Fat
Plasma lipids
Triglycerides
d (mg/dL plasma) M 113
b 102
b 28
a 108
b 100
b 40
a NS \0.001 NS
SD 36 20 6 35 42 18
Total cholesterol (mg/dL plasma) M 104.3
b 67.2
a 73.7
a 82.5
a 73.8
a 73.7
a NS \0.001 \0.01
SD 14.5 11.0 9.5 17.2 10.5 11.2
HDL-Cholesterol (mg/dL plasma) M 83.1
b 45.4
a 50.5
a 61.5
a 54.7
a 58.6
a NS \0.001 \0.001
SD 13.3 7.0 6.2 12.3 10.7 10.4
Liver lipids
Total lipids
d (mg/g fresh wt) M 39.6
a 48.8
ab 58.7
b 42.3
a 61.4
b 82.2
c \0.001 \0.001 NS
SD 5.4 10.4 9.0 5.5 10.0 15.3
Triglycerides
e (mg/g fresh wt) M 14.9
ab 11.7
a 25.3
b 14.3
a 25.1
b 46.3
c \0.001 \0.001 \0.01
SD 5.6 6.3 12.0 5.2 8.7 6.9
Cholesterol
d (mg/g fresh wt) M 2.00
a 2.98
b 4.74
c 2.15
a 3.40
b 7.24
c \0.001 \0.001 \0.01
SD 0.22 0.43 0.80 0.25 0.45 1.02
Phospholipids (mg/g fresh wt) M 23.0
a 25.2
a 24.7
a 23.5
a 25.0
a 26.0
a NS NS NS
SD 1.9 2.8 4.1 3.1 2.4 3.5
NS not signiﬁcant, SD standard deviation
a, b, c Group means (M) with different superscript letters within rows and within the same zinc level signiﬁcantly differ (p\0.05; Tukey test)
d ANOVA after ln transformation of the data
e ANOVA after x
1/2 transformation of the data
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not altered by any of the dietary treatments.
Fatty Acid Composition of Liver Phospholipids
Table 5 presents the fatty acid pattern in the PL extracted
from the liver in Experiment 1. Total molar proportions of
saturated fatty acids (SFA) were comparable across dietary
treatments. However, the percentages of 16:0 and 18:0 sig-
niﬁcantly differed among groups (p\0.001). Palmitic acid
(16:0) was the major SFA in the CT groups, whereas 18:0
dominatedintheBTandSFgroups.Oleicacid(18:1)wasthe
predominant monounsaturated fatty acid (MUFA) in all
groups. The highest mean percentage of this fatty acid was
recorded in the BT groups. As expected, the SF diets
increasedthetotalpercentagesofn-6PUFA,especiallythose
of 18:2, 20:4 and 22:4, and depressed the percentages of n-3
PUFA, leading to substantially higher ratios of n-6 PUFA to
n-3 PUFA in the SF-fed groups. Signiﬁcant Zn effects were
noted in the case of linoleic (18:2), c-linolenic (18:3n-6) and
docosapentaenoic acid (22:5n-3), which were present in
higherproportionswhentheratswerefedthelow-ZnBTand
Table 5 Fatty acid composition of liver phospholipids (mol/100 mol total fatty acids) (Experiment 1)
Diet Zn concentration Zinc: 7 lg/g Zinc: 100 lg/g ANOVA: p values
Fat supplement CT BT SF CT BT SF Zn Fat Zn 9 Fat
Sum SFA
e M 41.1
a 40.0
a 38.7
a 40.3
a 41.6
a 39.3
a NS \0.05 NS
SD 2.9 1.9 2.0 3.1 1.4 0.7
16:0 M 21.7
b 15.9
a 14.0
a 22.3
c 17.3
b 14.2
a NS \0.001 NS
SD 2.4 1.1 0.9 2.0 2.0 1.1
18:0 M 18.0
a 22.9
b 23.4
b 16.8
a 23.2
b 23.9
b NS \0.001 NS
SD 1.4 1.8 1.7 1.5 1.4 1.4
Sum MUFA
f M 5.53
b 4.16
a 4.72
a 5.73
b 4.01
a 4.20
a NS \0.001 NS
SD 0.77 0.64 0.76 1.14 0.56 0.45
18:1 M 3.51
a 4.16
a 3.55
a 3.61
b 4.01
b 2.83
a NS 0.001 NS
SD 0.62 0.64 0.78 0.81 0.56 0.24
Sum n-6 PUFA M 40.2
a 41.0
a 49.8
b 40.9
b 39.5
a 48.0
b NS \0.001 NS
SD 2.5 1.2 1.2 2.8 1.3 1.2
18:2 M 7.14
a 5.76
a 10.53
b 7.26
b 4.63
a 7.60
b \0.001 \0.001 0.001
SD 0.81 1.07 1.61 0.99 0.53 1.25
18:3 M 0.23
b 0.10
a 0.21
b 0.16
b 0.07
a 0.13
b \0.001 \0.001 NS
SD 0.06 0.08 0.07 0.05 0.04 0.03
20:3 M 1.26
a 1.37
a 1.07
a 1.56
a 1.60
a 1.21
a NS NS NS
SD 0.85 0.75 0.46 0.74 0.97 0.65
20:4 M 30.8
a 33.1
b 35.0
b 31.2
a 32.6
a 36.7
b NS \0.001 NS
SD 2.4 1.6 1.2 2.8 1.6 0.9
22:4
d M 0.53
a 0.61
a 1.85
b 0.50
a 0.62
a 1.74
b NS \0.001 NS
SD 0.06 0.12 0.18 0.07 0.11 0.29
Sum n-3 PUFA M 13.2
b 14.9
b 7.1
a 13.0
b 14.6
c 8.5
a NS \0.001 NS
SD 1.3 1.7 0.9 1.6 0.9 0.9
22:5
d M 0.97
b 1.53
c 0.68
a 0.94
b 1.18
b 0.61
a \0.01 \0.001 NS
SD 0.15 0.26 0.07 0.15 0.31 0.11
22:6 M 12.2
b 13.3
b 6.4
a 12.1
b 13.4
b 7.8
a NS \0.001 NS
SD 1.3 1.8 0.9 1.5 0.8 0.9
Sum n-6/Sum n-3 PUFA
d M 3.07
a 2.79
a 7.02
b 3.17
a 2.72
a 5.74
b \0.05 \0.001 \0.05
SD 0.25 0.35 0.98 0.32 0.19 0.70
NS not signiﬁcant, SD standard deviation
a, b, c Group means (M) with different superscript letters within rows and within the same zinc level signiﬁcantly differ (Tukey test, p\0.05)
d ANOVA after ln transformation of the data
e The sum of saturated fatty acids (SFA) includes small amounts of 14:0 (\0.6 mol%) and 21:0 (\0.5 mol%)
f The sum of monounsaturated fatty acids (MUFA) includes small amounts of 16:1 (about 1.2 mol%), 20:1 (\0.1 mol%) and 22:1 (about
0.8 mol%) in the case of the CT groups, and 20:1 (0.2 mol%) and 22:1 (about 1.0 mol%) in the case of the SF groups
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highly signiﬁcant Zn 9 fat interaction observed for 18:2
(p = 0.001) is basically due to the different direction and
height of response to the dietary fat level among the corre-
spondinglow-andhigh-Zngroups.Thisdieteffecton18:2is
also reﬂected in a signiﬁcant Zn 9 fat interaction of the n-6
PUFA to n-3 PUFA ratio (p\0.05).
Experiment 2
Energy Intake and Final Live Weight
InExperiment2,inwhichfoodintakeofthehigh-ZnBTand
SF diets was restricted to amounts consumed by the animals
offered the corresponding low-Zn diets, ﬁnal live weights
werenotaffectedbythedifferenceinZnsupply,whereasthe
animals allowed to consume the high-Zn SF diet ad libitum
reachedsigniﬁcantlyhigherﬁnalliveweights(Table 6).ME
intakeandﬁnalliveweightsoftheratsfedthelow-ZnSFdiet
were lower (about13%;p\0.01)than thosefedthelow-Zn
BT diet. As in Experiment 1, ME intake per gram weight
gain was reduced by the high-Zn diets, presumably due to a
slightly leaner tissue gain.
Zinc Status
Plasma and femur Zn concentrations and plasma activity of
the alkaline phosphatase (AP) were markedly reduced
(p\0.001) by the marginal dietary Zn supply in Experi-
ment 2 (Table 6). Fat source did not signiﬁcantly (p[0.05)
affect these parameters.
Plasma and Liver Lipids
Plasma concentrations of TAG, TC and HDL-C were not
signiﬁcantly altered by the dietary Zn level in Experiment 2
(Table 7). TAG concentrations in the SF groups were lower
than those in the BT groups. But plasma TC and HDL-C
concentrations were not signiﬁcantly affected by fat source.
The livers of the rats consuming the corresponding low- and
high-Zn BT and SF-diets in equivalent quantities had
comparable concentrations of total lipids, cholesterol and
PL (Table 7). However, the animals fed the high-Zn SF diet
ad libitum showed a signiﬁcantly (p\0.05) increased
hepatic TAG content. PL concentrations were about 10%
higher in the SF-fed than in the BT-fed animals.
Discussion
The present experiments were designed to investigate the
effect of a moderate Zn deﬁciency on growth and selected
features of lipid metabolism in weanling rats fed diets that
greatly differed in fat level and fat source. As expected, the
low-Zn diets (7 lg/g supplemental zinc) were associated
with notable reductions in food and energy intake and ﬁnal
Table 6 Effect of high-fat diets differing in Zn concentration and fat source on energy (ME) intake, ﬁnal live weight, plasma and femur Zn
concentration, and plasma alkaline phosphatase activity in weanling rats fed high-fat diets (Experiment 2)
Zinc (lg/g diet) 7 100 7 100 100 ANOVA
e
Fat source BT BT SF SF SF p values
Feeding protocol
f AL RF AL RF AL Zn Fat Zn 9 Fat
ME intake
d (kJ/d) M 218 208 189
a 185
a 256
b NS \0.01 NS
SD 33.8 3.2 20.3 4.7 8.0
Final live weight (g) M 207 202 179
a 186
a 237
b NS \0.001 NS
SD 14.0 5.7 19.4 7.4 9.9
ME intake/wt gain
d (kJ/g) M 38.7 37.8 40.8
a 37.8
a 38.2
a \0.05 NS NS
SD 1.7 0.6 2.4 2.1 1.7
Plasma zinc (lg/mL) M 0.91 1.33 0.80
a 1.38
b 1.20
b \0.001 NS NS
SD 0.08 0.32 0.12 0.20 0.11
Femur zinc (lg/g fresh wt) M 52.6 138.8 51.4
a 131.3
b 126.5
b \0.001 NS NS
SD 6.6 6.4 5.8 10.4 11.0
Plasma AP activity (mU/mL) M 505 631 520
a 737
b 628
c \0.001 NS NS
SD 29 83 106 62 65
NS not signiﬁcant, SD standard deviation
a, b, c Means (M) with different superscript letters among SF groups signiﬁcantly differ (p\0.05; Tukey test)
d ANOVA after ln transformation of the data
e Bifactorial ANOVA (without group fed SF diet with 100 lg Zn/g ad libitum)
f Feeding protocol: AL ad libitum, RF restricted-fed
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123live weights compared to animals fed the high-Zn diets
(100 lg/g supplemental zinc), but without the complica-
tions that would arise from feeding severely Zn-deﬁcient
diets, i.e. growth arrest, development of a cyclic feeding
pattern, conspicuous inanition, and the manifestation of
clinical deﬁciency symptoms [1–3]. The increase in dietary
fat level implied a pronounced difference in energy intake
as carbohydrate and fat in Experiment 1. Available car-
bohydrates (cornstarch and sucrose) and fat accounted for
about 69 and 8% of ME intake of the rats fed the low-fat
diets, respectively, whereas carbohydrates contributed no
more than about 22% and fat at least 55% of ME intake in
the case of the high-fat diets (Table 1). There was a small
difference in ME content between the BT and SF diets due
the fact that fat digestibility was signiﬁcantly lower for the
BT diets than for the SF and CT diets (Table 3).
In Experiment 1, in which all diets were fed ad libitum,
meandailyMEintakeandﬁnalliveweightswerecomparable
amongtheratsfedthethreehigh-Zndietsregardlessofdietary
fatlevelandfatsource.This,however,wasnotthecaseamong
the animals fed the corresponding low-Zn diets. The animals
given the low-Zn SF diet displayed the greatest reductions in
ME intake (about 30%) and ﬁnal live weights (about 28%)
relative to those consuming the corresponding high-Zn diet
(Table 3). Again in Experiment 2, daily ME intake and ﬁnal
live weights were signiﬁcantly lower for the rats fed the low-
ZnSFdietascomparedtothelow-ZnBTdiet(Table 6).This
observationsupportsapreviousstudyinwhichmarginallyZn-
deﬁcient diets enriched with sunﬂower or olive oil depressed
food intake and weight gain of young rats to a greater extent
than did low-Zn diets containing equivalent percentages of
beef tallow, butterfat or coconut oil [7]. Although it is a
commonobservationthatbothfoodintakeandgrowthrateare
depressed by dietary Zn deﬁciency, previous studies have
clearly shown that growth retardation cannot be attributed to
the lower foodorenergyintake.Chesters andQuarterman[1]
observed that force-feeding Zn-deprived rats a Zn-deﬁcient
diet not only failed to alleviate the growth arrest but rapidly
induced signs of severe ill-health and morbidity. This ﬁnding
hasbeenconﬁrmedbylaterinvestigatorsreportingthatyoung
rats with an initially normal Zn status cease to tolerate force-
feeding of Zn-deﬁcient diets in amounts exceeding voluntary
consumption after about 9–11 days [16–18]. These studies
demonstratethatadeﬁcitofzincpersemustberesponsiblefor
the growthretardation.Itiswell established thata lackofzinc
impairs cell division, differentiation and growth in various
species, including microorganisms, plants and vertebrates
(see [19] for review).
Table 7 Effect of high-fat diets differing in Zn concentration and fat source on plasma and liver lipid concentrations (Experiment 2)
Zinc (lg/g diet) 7 100 7 100 100 ANOVA
d
Fat source BT BT SF SF SF p values
Feeding protocol
e AL RF AL RF AL Zn Fat Zn 9 Fat
Plasma lipids
Triglycerides (mg/dL plasma) M 95.6 101.8 48.1
a 60.4
a 76.4
a NS \0.001 NS
SD 15.6 31.5 14.6 33.7 32.3
Cholesterol (mg/dL plasma) M 85.5 84.4 72.4
a 92.5
a 89.6
a NS NS NS
SD 9.4 17.0 13.2 14.3 19.2
HDL-Cholesterol (mg/dL plasma) M 44.4 39.6 46.0
a 51.1
a 58.1
a NS NS NS
SD 8.3 7.7 6.6 11.8 13.8
Liver lipids
Total lipids (mg/g fresh wt) M 51.4 50.9 64.4
a 71.0
ab 82.7
b NS \0.001 NS
SD 9.5 5.4 7.7 8.4 12.8
Triglycerides (mg/g fresh wt) M 16.2 16.8 19.7
a 25.6
a 35.0
b NS \0.05 NS
SD 6.4 4.7 5.9 6.9 11.7
Cholesterol
c (mg/g fresh wt) M 2.53 2.37 4.67
a 4.65
a 5.21
a NS \0.001 NS
SD 0.47 0.08 0.80 0.53 0.72
Phospholipids (mg/g fresh wt) M 25.4 24.4 28.5
a 27.3
a 26.6
a NS \0.001 NS
SD 1.8 2.5 1.3 0.7 1.8
NS not signiﬁcant, SD standard deviation
a, b Group means (M) with different superscript letters among SF diets signiﬁcantly differ (p\0.05; Tukey test)
c ANOVA after ln transformation of the data
d Bifactorial ANOVA (without group fed SF diet with 100 lg Zn/g ad libitum)
e Feeding protocol: AL ad libitum, RF restricted-fed
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123Zn concentrations in plasma and femur and AP activity
in plasma, known to be sensitive indicators of Zn status
under experimental conditions, responded markedly to the
difference in dietary Zn nutrition in both experiments
(Tables 3, 6). In Experiment 1, the rats fed the SF diets had
the lowest plasma Zn concentrations at either dietary Zn
level. This ﬁnding may suggest a decreased intestinal Zn
availability as a possible explanation for the lower ﬁnal live
weights of the rats consuming the low-Zn SF diet. In
Experiment 2, mean plasma Zn concentration was again
lower (12%) in the low-Zn SF than in the low-Zn BT
group, but the difference failed to be statistically signiﬁ-
cant. In addition, femur Zn concentrations and plasma AP
activities, which reﬂect Zn status over a longer period than
plasma zinc, were comparable between the low-Zn BT and
SF groups in either experiment, and thus argue against the
idea that enriching the diets with sunﬂower oil may have
lowered Zn availability and hence growth of the animals.
Regarding the effect of dietary Zn depletion on plasma
or serum lipids, the literature data are not uniform. Some
authors reported that Zn-deﬁcient rats had decreased tri-
glyceride (TAG) concentrations compared to pair-fed or
ad libitum-fed control animals [20, 21], whereas others
found that Zn depletion did not signiﬁcantly alter TAG
levels [22–24]. In a series of studies, in which young rats
were force-fed Zn-deﬁcient diets containing different fat
levels and fat sources, TAG concentrations were increased
or remained unaffected relative to values of control rats
force-fed equal quantities of the same diets with adequate
Zn supply [18, 24, 25]. In our experiments, the difference
in dietary Zn supply did not signiﬁcantly affect plasma
TAG concentrations regardless of fat content and fat source
(Tables 4, 7). Thus, it does not appear that a moderate Zn
deﬁcit plays a primary role in modulating TAG levels in
circulating blood. In contrast, fat source signiﬁcantly
inﬂuenced plasma TAG concentrations. Proposed mecha-
nisms explaining the lower plasma TAG levels in response
to the ingestion of polyunsaturated relative to saturated fats
include a decreased rate of lipoprotein secretion [26–29]
and an increased lipoprotein clearance from circulation
[30, 31]. Gene expression studies provide support for both
of these mechanisms (see [32] for a recent review).
The effect of Zn deﬁciency on plasma or serum cho-
lesterol concentrations has also been found to differ among
previous studies. In several investigations, Zn depletion of
young rats was associated with lower cholesterol levels
[20, 21, 33–35], whereas in others cholesterol values of Zn-
depleted rats did not differ from those of pair-fed or
ad libitum-fed control animals [22, 23, 36–38]. Young rats
force-fed Zn-deﬁcient diets in quantities above those vol-
untarily consumed by Zn-deprived animals showed rather
regularly elevated cholesterol levels compared to animals
force-fed equivalent amounts of Zn-adequate diets [19, 25].
In Experiment 1 of our study, plasma total and HDL cho-
lesterol concentrations were also higher in the rats con-
suming the low-Zn, low-fat diet as compared to the
corresponding high-Zn CT diet. In both experiments,
however, the rats fed the high-fat diets displayed compa-
rable cholesterol levels regardless of dietary Zn level, fat
source and energy intake. This ﬁnding agrees with a former
study in which serum cholesterol concentrations were
comparable among rats fed diets containing 20% fat as beef
tallow or sunﬂower oil [39]. A possible explanation for the
lower HDL-cholesterol levels in plasma of the animals
given the high-fat diets may be the former observation that
activation of the peroxisome proliferator-activated receptor
alpha (PPARa) decreases circulating HDL in rodents [40].
A few former investigations found that dietary Zn
depletion did not alter TAG concentrations in the liver of
young rats [33, 41], whereas others reported reduced con-
tents compared to animals fed Zn-adequate diets either
ad libitum [21, 38] or in restricted amounts [42]. Our
experiments indicate that dietary fat content and level of
energy intake have a greater impact on liver lipids than a
moderate Zn deﬁcit. In Experiment 1, the livers of the ani-
mals fed the high-Zn BT and SF diets had signiﬁcantly
higher TAG contents than those given the corresponding
low-Zn diets (Table 4), but their energy intake was also
signiﬁcantly higher due to the ad libitum feeding protocol
(Table 3). In Experiment 2, in which intake of the high-Zn
diets was restricted to the intake of the respective low-Zn
diet, the difference in dietary Zn intake did not alter hepatic
TAGconcentrations.Buttheratsofferedthehigh-ZnSFdiet
for ad libitum intake had a markedly higher hepatic TAG
content than those consuming the SF diet in lower amounts
(about 27%). Data documented by Cunnane [41] also sug-
gest that a difference in food intake of about 20% may be
sufﬁcienttoaffectTAGlevelsintheliverofgrowingratsfed
diets supplemented with greatly different levels of zinc.
The fat source was a signiﬁcant factor for hepatic lipid
concentrations in both experiments of our study. The SF
diet effected substantially higher TAG concentrations in
the liver than the BT diet. This agrees with numerous
former investigations reporting that diets containing oils
rich in unsaturated fatty acids (including sunﬂower oil
among other vegetable oils) increase hepatic TAG con-
centrations compared to saturated fats [21, 29, 43, 44]o rt o
diets low in fat [45]. Various mechanisms have been pro-
posed for the differences in hepatic TAG concentration.
Monsma and Ney [45] reported that the intestinal absorp-
tion of the stearate-rich diets was reduced. A reduced fat
digestibility was also evident in our study for the BT diet
compared to the other diets (as discussed before). The
lower digestibility of the beef tallow, however, must be
considered insufﬁcient to explain the lower hepatic TAG
levels in our experiments for the following reasons. First,
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those observed for the rats given the low-fat control diets.
Secondly, ME intake per unit weight gain was closely
comparable among diets within the same dietary Zn level
in both experiments. Finally, other workers demonstrated
that PUFA-rich diets reduce the assembly and secretion of
VLDL in the liver (see [32, 46] for reviews).
Previous studies, in which low-fat diets were fed to
growing rats, showed that dietary Zn depletion of rats does
not signiﬁcantly alter hepatic cholesterol concentrations
[21, 33, 47]. The livers of the rats fed the low-fat diets in
Experiment 1 of our study also had comparable cholesterol
concentrations regardless of the dietary Zn level. This was
also true for the high-fat diets in Experiment 2, in which
intake of the high-Zn diets was restricted. Therefore, the
signiﬁcant difference in liver cholesterol concentrations
between the low-Zn and high-Zn BT and SF groups in
Experiment 1 must be attributed to the difference in energy
or fat intake. Higher cholesterol concentrations in the liver
of young rats in response to an increased dietary fat supply
have been observed previously [48, 49]. The rats con-
suming the SF diets had the highest cholesterol concen-
trations in both experiments of our study. This effect is
consistent with numerous former studies showing higher
hepatic cholesterol concentrations in rats fed diets enriched
with (15% or more) unsaturated vegetable oils as compared
to diets supplemented with saturated fats [44, 48–50].
Increased hepatic cholesterol levels in response to the
feeding of diets rich in n-6 PUFA may result from a lower
formation and secretion of VLDL as discussed before in
the case of hepatic TAG concentrations.
Previous studies with young rats have found that
phospholipid (PL) concentrations are barely affected by
feeding Zn-deﬁcient diets [18, 41, 47] or by different fat
sources [45]. In agreement, the hepatic PL concentrations
remained closely comparable in the present study despite
substantial differences in zinc, fat and energy intake and
dietary fat source. The fatty acid composition of the hepatic
PL also reﬂects a remarkable resistance to the dietary
variables, most notable in the similar total percentages of
saturated (SFA) across diets. There is no evidence from our
data that the conversion of linoleic and a-linolenic acid into
longer-chain PUFA might have been impaired by the
moderate Zn deﬁciency, even though linoleic, c-linolenic
(18:3n-6) and docosapentaenoic (20:5n-3) acid were pres-
ent in signiﬁcantly higher proportions in the PL of the rats
fed the low-Zn diets than in those given the corresponding
high-Zn diets. The percentages of arachidonic (20:4n-6)
and docosahexaenoic (22:6n-3) acid, the main end products
of linoleic and a-linolenic acid, respectively, were closely
comparable between the corresponding low- and high-Zn
groups. This supports those former studies showing that
dietary Zn deﬁciency per se does not impair the chain
elongation/desaturation pathway of essential fatty acids
(see [51] for review).
As expected, the diet enriched with sunﬂower oil, con-
taining linoleic acid as dominant fatty acid, markedly
promoted the incorporation of n-6 PUFA, especially ara-
chidonic acid, into the PL, mostly at the expense of
docosahexaenoic acid. A signiﬁcant effect of the dietary fat
level is evident among the SFA. The hepatic PL of the rats
fed the low-fat diets contained higher proportions of pal-
mitic than stearic acid. The proportions of these two SFA
were reversed in the case of the animals consuming the
high-fat diets. Two major reasons may explain this shift.
First, hepatic de novo lipogenesis was evidently the major
source of palmitic acid in the liver of the CT-fed rats,
whereas SFA intake was low. In support, the activity of
glucose-6-phosphate dehydrogenase, which belongs to the
lipogenic enzyme family and closely correlates with the
rate of fatty acid synthesis in the liver [15], was very much
higher in the CT groups than in the high-fat groups
(Table 3). Secondly, stearic acid was presumably desatu-
rated to oleic acid in the liver of the CT-fed animals to a
major extent, since its intake was also low, yet its pro-
portions in the PL fraction approximately as high as those
in the high-fat groups, for which oleic acid was available in
appreciable amounts from dietary intake.
Conclusion
Taken together, the current study shows that diets highly
enriched with either beef tallow or sunﬂower oil have a
quantitatively greater impact on plasma and liver lipid
composition than a moderate Zn deﬁciency. Yet, none of
the lipid parameters seems to offer a possible explanation
why the marginal Zn supply caused a greater growth
retardation when the diet contained sunﬂower oil instead of
beef tallow. Fatty acids certainly were the major energy
source in either of these groups. However, in the SF diet
over 85% of the fatty acids were unsaturated, mainly lin-
oleic acid, whereas the BT diet contained less unsaturated
fatty acids (about 52%). Considering the limited dietary
supply of carbohydrates and SFA from the SF diet and the
need of SFA in the synthesis of membrane and storage
lipids, it is conceivable that the SF-fed rats may have lar-
gely relied on PUFA as energy source. Mitochondrial and
peroxisomal b-oxidation of unsaturated fatty acids,
including linoleic and oleic acid, requires D
3,D
2 enoyl-CoA
isomerase (ECI, EC 5.3.3.8) as key auxiliary enzyme [52,
53]. In the liver of young rats force-fed Zn-deﬁcient diets,
mRNA proﬁling showed that the transcription of genes
coding for enzymes of the b-oxidation scheme, including
ECI, was markedly reduced compared to Zn-adequate
control animals [54, 55]. Further research is needed to
300 Lipids (2012) 47:291–302
123investigate whether and to what extent a moderate Zn
deﬁciency may lead to a reduced ECI activity as a possible
explanation of the consistently attenuating effect of diets
enriched with sunﬂower oil on weight gain of weanling rats
in the present experiments and in a previous study [7].
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